Find clinical trials for Lung Cancer in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near San Francisco, CA, USA:
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
San Francisco, California, United States and 17 other locations
with osimertinib in treating patients with EGFR-mutated stage IV lung cancer. Alisertib may stop the growth of tumor cells ...
Phase 1
San Francisco, California, United States
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
San Francisco, California, United States and 30 other locations
Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before surgery. Osimertinib may stop the growth of tumor...
Phase 2
San Francisco, California, United States and 2 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...
Phase 1
Stanford, California, United States and 25 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Oakland, California, United States and 97 other locations
KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...
Phase 3
San Francisco, California, United States and 156 other locations
as a single agent and in combination with pembrolizumab in subjects with locally advanced and unresectable or metastatic non-small cell lung ...
Phase 1
San Francisco, California, United States and 26 other locations
This study will consist of a Phase 1b and Phase 2 portion. The Phase 1b portion will enroll first followed by the Phase 2 portion. Each cycle of trea...
Phase 1, Phase 2
Stanford, California, United States and 2 other locations
This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...
Phase 2
Santa Rosa, California, United States and 62 other locations
Clinical trials
Research sites
Resources
Legal